Botta P,Demmou L,Kasugai Y,Markovic M,Xu C,Fadok J P and Rudolph U .2015 .Regulating anxiety with extrasynaptic inhibition. Nat. Neurosci., 18(10) : 1493-1500.
Boyce S,Smith D,Carlson E,Hewson L,Rigby M,O'Donnell R,Harrison T,Rupniak N M .2001 .Intra-amygdala injection of the substance P (NK1 receptor) antagonist L-760735 inhibits neonatal vocalisations in guineapigs. , 41 : 130-137.
Commons KG,Valentino RJ .2002 .Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus. J. Comp. Neurol., 447 : 82-97.
Cui F,Shi K,Zhang L,Tao A,Kawashima Y .2006 .Biodegradable nanoparticles loaded with insulinphospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation. J. Contr. Rel., 114(2) : 242-250.
Ebner K and Singewald N .2006 .The role of substance P in stress and anxiety responses. Amino Acids, 31(3) : 251-272.
Ebner K,Muigg P,Singewald G,Singewald N G .2008 .Substance P in stress and anxiety: NK-1 receptor antagonism interacts with key brain areas of the stress circuitry. , 1144(1) : 61-73.
Ebner K and Singewald N .2005 .Effects of NK1 receptor antagonist administration on basal and stressinduced substance P release in the amygdala. J. Neurochem., 94(Suppl) : 183.
Frick A,Åhs F,Palmquist Å M,Pissiota A,Wallenquist U,Fernandez M,Furmark T .2016 .Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multitracer PET study. Mol. Psych, 21(10) : 1400-1407.
Froger N,Gardier AM,Moratalla R,Alberti I,Lena I,Boni C,De Felipe C,Rupniak NM,Hunt SP,Jacquot C,Hamon M,Lanfumey L M .2001 .5- hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knockout mice mimic antidepressantinduced desensitization. J. Neurosci., 21 : 8188-8197.
Fuchs RA,Weber SM,Rice HJ,Neisewander JL HJ .2002 .Effects of excitotoxic lesions of the basolateral amygdala on cocaine-seeking behavior and cocaine conditioned place preference in rats. Brain Res., 929 : 15-25.
Gadd CA,Murtra P,De Felipe C and Hunt SP P .2003 .Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse. J. Neurosci., 23(23) : 8271-8280.
Garcia-Recio S,Gascon P .2015 .Biological and pharmacological aspects of the NK1-receptor. Bio Med. Res. Int.,, : .
Gupta U,Singh V K,Kumar V,Khajuria Y .2014 .Spectroscopic studies of cholesterol: Fourier transform infra-red and vibrational frequency analysis. Mater. Focus, 3(3) : 211-217.
Halder S,Mehta AK,Kar R,Mustafa M,Mediratta PK,Sharma KK .2011 .Clove oil reverses learning and memory deficits in scopolamine-treated mice. Planta Med, 77(08) : 830-834.
Hidayah N .2018 .The effect of papain enzyme dosage on the modification of egg-yolk lecithin emulsifier product through enzymatic hydrolysis reaction. Int. J. Tech., 9(2) : 380-389.
.1986 .Guide for the care and use of laboratory animals (No. 86). US Department of Health and Human Services, : .
Maubach KA,Martin K,Smith DW,Hewson L,Frankshun RA,Harrison T,Seabrook GR .2001 .Substance P stimulates inhibitory synaptic transmission in the guinea pig basolateral amygdala in vitro. , 40 : 806-817.
Mohammadi M,Ghanbarzadeh B,Hamishehkar H B .2014 .Formulation of nanoliposomal vitamin D3 for potential application in beverage fortification. Adv. Pharm. Bull., 4(Suppl) : 569.
Nguyen TL,Nguyen TH,Nguyen DH .2017 .Development and in vitro evaluation of liposomes using soy lecithin to encapsulate paclitaxel. 2017: Article ID 8234712., : .
Nikalje AP .2015 .Nanotechnology and its applications in medicine. Med, 5(2) : 081-089.
Parkinson JA,Crofts HS,McGuigan M,Tomic DL,Everitt BJ,Roberts AC .2001 .The role of the primate amygdala in conditioned reinforcement. J. Neurosci., 21 : 7770-7780.
Davis Parsafar P,EL Parsafar P .2018 .The function of emotions: When and why emotions help us. Cham: Spr. Int. Pub., : 9-23.
Perusini JN,Fanselow MS .2015 .Neurobehavioral perspectives on the distinction between fear and anxiety. , 22(9) : 417-425.
Ribeiro-da-Silva A,HE o okfelt T .2000 .Neuroanatomical localisation of substance P in the CNS and sensory neurons. , 34 : 256-271.
Santarelli L,Gobbi G,Debs PC,Sibille EL,Blier P,Hen R,Heath MJ R .2001 .Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc. Natl. Acad. Sci. USA, 98 : 1912-1917.
Selvan P,Malathi RR,Rajan RR .2016 .Effect of 4- Allyl-2-methoxyphenol (eugenol) on motor coordination in subacute restraint stress Induced wistar albino rats. J. App. Pharm., 6(11) : 120-125.
Sharma M,Rauniar GP,Das BP .2012 .Experimental study of various central nervous system effects of eugenol in mice and rats. , 10(3) : 208-214.
Shults CW,Quirion R,Chronwall B,Chase TN,O'Donohue TL TN .1984 .A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system. Peptides, 5 : 1097-112.
Siddiqui RA,Simjee SU,Kabir N,Ateeq M,Shah MR,Hussain SS .2019 .N-(2-hydroxyphenyl) acetamide and its gold nanoparticle conjugation prevent glycerol-induced acute kidney injury by attenuating inflammation and oxidative injury in mice. Mol. Cell Biochem, 450(1-2) : 43-52.
Silvianti F,Siswanta D,Aprilita NH,Kiswandono AA .2017 .Adsorption characteristic of iron onto Poly [eugenol-co-(divinyl benzene)] from Aqueous solution. J. Nat., 17(2) : 108-117.
Ständer S and Yosipovitch G .2019 .Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus. Br. J. Dermatol., 181(5) : 932-938.
Tovoten P,Fadok J P and Luthi A .2015 .Neuronal circuits for fear and anxiety. Nat. Rev. Neurosci., 16(6) : 317-331.
Varty GB,Cohen-Williams ME,Morgan CA,Pylak U,Duffy RA,Lachowicz JE,Carey GJ,Coffin VL .2002 .The gerbil elevated plus-maze II: Anxiolyticlike effects of selective neurokinin NK1 receptor antagonists. , 27 : 371-379.